Clinical Trials Logo

Blindness clinical trials

View clinical trials related to Blindness.

Filter by:

NCT ID: NCT00634972 Terminated - Clinical trials for Retinopathy of Prematurity

Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity

ROP
Start date: November 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to test whether ACULAR, a nonsteroidal anti-inflammatory eye drop medication, can prevent the development of retinopathy of prematurity (ROP) and/ or decrease its severity.In this study ACULAR will be compared to a placebo (artificial tear). The hypothesis would be that ACULAR treatment will decrease the incidence of moderate to severe ROP (grade II and above)by 50%.

NCT ID: NCT00589407 Terminated - Neck Pain Clinical Trials

Unilateral Blindness/ Unilateral Deafness-relation to Neck Pain

Start date: n/a
Phase: N/A
Study type: Observational

Neck pain is a common complaint in the general population affecting 10-15% of the general population. females more than men. Known risk factors are: Trauma, Repetitive lifting of heavy objects at work, driving vibrating vehicles, frequents diving from boards and smoking. No study dealt with the possible role of unilateral loss of vision or hearing as a risk factor for the development of neck pain. Intuitively, one might suspect that unilateral blindness or deafness will lead to a tilted position of the head, in order to cover a better visual/audio field. This position, in time, might lead to the development of neck pain. Our hypothesis is that patients with unilateral blindness/deafness will suffer from neck pain more frequently than the general population.

NCT ID: NCT00262509 Terminated - Blindness Clinical Trials

Emergency Egress and Information System for Persons With Vision Loss

Start date: September 2008
Phase: N/A
Study type: Interventional

The purpose of the research project is to develop and evaluate an emergency egress system for persons with visual impairment, which would use existing lighted exit signage to provide egress information at a distance of up to 100 feet.